Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Curious about BPC-157 nasal spray vs
TB-500 operates primarily through actin polymerization and cell migration signaling, without the angiogenic mechanism that defines research into this compound
In rat studies, BPC-157 demonstrated healing effects in various colitis models, including cysteamine-induced colitis, improved intestinal anastomosis healing, and promoted closure of gastrointestinal fistulascomplications relevant to Crohn's disease.[4][5][3] The proposed mechanisms include interaction with the nitric oxide system, angiogenic effects, endothelium protection, and modulation of growth factor expression.[1][6] Critical limitations include the lack of published results from controlled human trials, absence of FDA approval, and concerns about products being sold online without regulatory oversight.[2] The peptide was temporarily banned by the World Anti-Doping Agency in 2022, though it is not currently listed as banned.[2] Given these limitations, BPC-157 cannot be recommended as standard therapy for ulcerative colitis or Crohn's disease based on current evidence
Applications in Research: Chronic inflammation resolution models Skin, joint, and connective tissue regeneration Studies on gut permeability and barrier repair Anti-inflammatory and post-surgical recovery frameworks Combined angiogenesis and extracellular matrix signaling Storage & Handling: Store lyophilized powder at -20C in a light- and moisture-free environment
Market Positioning and Category Language The term "most effective peptide" appears within competitive market positioning language referenced in ProHealth's materials
US$ 27.78
US$ 26.69
US$ 25.46
US$ 20.54
US$ 25.15